PostEra: Dawn score and attention ranking
PostEra scores 26 out of 100 on the Dawn Index, built from 4 signals. It ranks #29 of 43 in Drug Discovery and Delivery (YC), #146 of 176 in YC Winter 2020, #415 of 534 in Healthcare (YC), #3616 of 4224 in Y Combinator.
What drives the PostEra Dawn score?
| Signal | Weight | Score (0 to 100) |
|---|---|---|
| Search scale | 20% | 36 |
| Search momentum | 20% | 30 |
| Site scale | 15% | 5 |
| Site momentum | 10% | 0 |
How does PostEra compare in Drug Discovery and Delivery (YC)?
| Rank | Brand | Dawn score |
|---|---|---|
| 1 | Shasqi | 59 |
| 2 | Rosebud Biosciences | 50 |
| 3 | Sequence Bio | 47 |
| 4 | Atlas Discovery | 46 |
| 5 | Quinn | 42 |
| 6 | Nabla Bio | 41 |
| 7 | WhiteLab Genomics | 41 |
| 8 | b12 Labs | 41 |
Where do the numbers come from?
Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.